Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10326788 | 0.88 | EPHX2 (0.36) | EPHX2CHRM2CHRM1 | |
| SCHEMBL27475816 | 0.85 | EPHX2 (0.38) | EPHX2CHRM2CHRM1 | |
| SCHEMBL472084 | 0.82 | EPHX2 (0.44) | EPHX2 | |
| SCHEMBL3933914 | 0.82 | — | — | |
| SCHEMBL16233622 | 0.77 | EPHX2 (0.39) | EPHX2 | |
| SCHEMBL12948927 | 0.77 | EPHX2 (0.39) | EPHX2 | |
| SCHEMBL14609409 | 0.77 | EPHX2 (0.39) | EPHX2 | |
| SCHEMBL4570339 | 0.76 | EPHX2 (0.41) | EPHX2 | |
| SCHEMBL1981954 | 0.73 | EPHX2 (0.37) | EPHX2 | |
| SCHEMBL4570341 | 0.73 | EPHX2 (0.37) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9793456-B2 | Molded resin body for surface-mounted light-emitting device, manufacturing method thereof, and surface-mounted light-emitting device | KANEKA CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| US-9793456-B2 | Molded resin body for surface-mounted light-emitting device, manufacturing method thereof, and surface-mounted light-emitting device | KANEKA CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| US-9496468-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2016-11-15 | — | — | US | disclosed |
| US-9496468-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2016-11-15 | — | — | US | disclosed |
| EP-2216336-B1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | KANEKA CORP (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-9178120-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2015-11-03 | — | — | US | disclosed |
| US-9178120-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2015-11-03 | — | — | US | disclosed |
| US-20150188008-A1 | CURABLE RESIN COMPOSITION, CURABLE RESIN COMPOSITION TABLET, MOLDED BODY, SEMICONDUCTOR PACKAGE, SEMICONDUCTOR COMPONENT AND LIGHT EMITTING DIODE | KANEKA CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| US-20150188008-A1 | CURABLE RESIN COMPOSITION, CURABLE RESIN COMPOSITION TABLET, MOLDED BODY, SEMICONDUCTOR PACKAGE, SEMICONDUCTOR COMPONENT AND LIGHT EMITTING DIODE | KANEKA CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| US-20150008455-A1 | MOLDED RESIN BODY FOR SURFACE-MOUNTED LIGHT-EMITTING DEVICE, MANUFACTURING METHOD THEREOF, AND SURFACE-MOUNTED LIGHT-EMITTING DEVICE | KANEKA CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20100267919-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100267919-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100222525-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100222525-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-09-02 | — | — | US | disclosed |
| US-7785715-B2 | Compound with at least two carbon-carbon double bonds such as triallyl isocyanurate; compound with SiH groups such as reaction product of 1,3,5,7 tetramethylcyclotetrasiloxane and triallyl isocyanurate; coupler; and not less than 5% by weight of rutile TiO2 | KANEKA CORPORATION (JP) | 2010-08-31 | — | — | US | disclosed |
| US-7785715-B2 | Compound with at least two carbon-carbon double bonds such as triallyl isocyanurate; compound with SiH groups such as reaction product of 1,3,5,7 tetramethylcyclotetrasiloxane and triallyl isocyanurate; coupler; and not less than 5% by weight of rutile TiO2 | KANEKA CORPORATION (JP) | 2010-08-31 | — | — | US | disclosed |
| EP-2216336-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | Kaneka Corporation (JP) | 2010-08-11 | — | — | EP | disclosed |
| EP-1967540-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-7371462-B2 | 1,3,5,7-tetramethylcyclotetrasiloxane and triallyl isocyanurate, a hydrosilylation catalyst, a silane coupling agent and/or an epoxy group-containing compound, and a silanol condensation catalyst | KANEKA CORPORATION (JP) | 2008-05-13 | — | — | US | disclosed |
| US-7371462-B2 | 1,3,5,7-tetramethylcyclotetrasiloxane and triallyl isocyanurate, a hydrosilylation catalyst, a silane coupling agent and/or an epoxy group-containing compound, and a silanol condensation catalyst | KANEKA CORPORATION (JP) | 2008-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267919-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | SMCHD1, SQLE, SMARCA5 | EPHX2 79/4885CHRM2 3206/4885CHRM1 2973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.